Silver Oak Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 3 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -60.26%
(FY 2023)
- Ebitda -61.10%
(FY 2023)
- Net Worth -8.91%
(FY 2023)
- Total Assets -2.99%
(FY 2023)
About Silver Oak Pharmaceuticals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shital Agrawal and Poonam Agarwal serve as directors at the Company.
- CIN/LLPIN
U24299GJ2021PTC125990
- Company No.
125990
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Sep 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Silver Oak Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shital Agrawal  | Director | 29-Sep-2021 | Current |
| Poonam Agarwal | Director | 29-Sep-2021 | Current |
Financial Performance of Silver Oak Pharmaceuticals.
Silver Oak Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 60.26% decrease in profit. The company's net worth dipped by a decrease of 8.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Silver Oak Pharmaceuticals?
Unlock access to Silver Oak Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Gujarat Smelting And Refining Company LimitedActive 40 years 6 monthsShital Agrawal and Poonam Agarwal are mutual person
- Anusakshi Engineering Private LimitedActive 12 years 10 months
Shital Agrawal and Poonam Agarwal are mutual person
- Pratt Muller Distributors LtdActive 34 years 3 months
Shital Agrawal and Poonam Agarwal are mutual person
- Silver Oak Country Clubs And Resorts LimitedActive 32 years 4 months
Shital Agrawal and Poonam Agarwal are mutual person
- Triveni Consultancy Pvt LtdActive 41 years 7 months
Shital Agrawal and Poonam Agarwal are mutual person
- I-Scale Innovation FoundationActive 7 years 8 months
Shital Agrawal and Poonam Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Silver Oak Pharmaceuticals?
Silver Oak Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Silver Oak Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Silver Oak Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
